ArticlePloS one2025
Comparative analysis of cervical cancer classification of DPAGCHE-enhanced Pap smear images using convolutional neural network models.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictive modeling for cervical cancer: existing AI approaches and the emerging role of vaginal microbiome.Frontiers in network physiology · 2026Article
- SegResDeiT: a hybrid SegNet-ResNet-50-DeiT framework for automated cervical cancer segmentation and classification.BMC medical imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer remains a significant cause of female mortality worldwide, primarily due to abnormal cell growth in the cervix. This study proposes an automated classification method to enhance detection accuracy and efficiency, addressing contrast and noise issues in traditional diagnostic approaches. The impact of image enhancement on classification performance is evaluated by comparing transfer learning-based Convolutional Neural Network (CNN) models trained on both original and enhanced images. This study employs transfer learning with pre-trained CNNs to classify preprocessed Pap smear images into three categories. Data augmentation, including rotations, flips, and shifts, enhances variability and prevents overfitting. The OneCycle learning rate schedule dynamically adjusts the learning rate, improving training efficiency. To enhance image quality, the Denoised Pairing Adaptive Gamma with Clipping Histogram Equalization (DPAGCHE) method improves contrast and reduces noise. The evaluation involves five pre-trained CNN models and the publicly available Herlev dataset, implemented in MATLAB Online. The ResNet50 model trained on the DPAGCHE-enhanced dataset achieves the highest classification performance, with 84.15% accuracy, along with improved specificity, recall, precision, and F1-score. ResNet50's residual connections mitigate vanishing gradient issues and enhance deep feature extraction. Accordingly, the DPAGCHE preprocessing significantly improves classification performance, leading to a 53.65% increase in F1-score and 44.29% in precision. In contrast, the Baseline CNN reaches only 66.67% accuracy, highlighting the advantage of deeper architectures combined with enhanced preprocessing. These findings suggest integrating DPAGCHE-enhanced preprocessing with deep learning improves automated cervical cancer detection. In particular, ResNet50 demonstrates the best performance, reinforcing the effectiveness of contrast enhancement and noise reduction in aiding classification models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.